Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Pfizer Inc. (PFE) had Debt to Capital Ratio of 0.39 for the most recently reported fiscal quarter, ending 2024-12-31.
| Income Statement Financials | |
$17.76B |
|
$410.00M |
|
$5.91B |
|
$11.85B |
|
$15.42B |
|
$2.35B |
|
$-2.36B |
|
$-10.00M |
|
$-10.00M |
|
$411.00M |
|
$411.00M |
|
$418.00M |
|
$411.00M |
|
$2.35B |
|
$4.14B |
|
5.66B |
|
5.70B |
|
$0.07 |
|
$0.07 |
|
| Balance Sheet Financials | |
$50.36B |
|
$18.39B |
|
$163.04B |
|
$213.40B |
|
$42.99B |
|
$57.41B |
|
$81.90B |
|
$124.90B |
|
$88.50B |
|
$-35.44B |
|
$88.50B |
|
5.67B |
|
| Cash Flow Statement Financials | |
$12.74B |
|
$2.65B |
|
$-17.14B |
|
$2.92B |
|
$1.11B |
|
$-1.81B |
|
$877.00M |
|
$-9.51B |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.17 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.39 |
0.73 |
|
66.73% |
|
13.21% |
|
13.21% |
|
-- |
|
-0.06% |
|
2.31% |
|
$9.84B |
|
-- |
|
-- |
|
-- |
|
0.08 |
|
0.54 |
|
1.55 |
|
58.08 |
|
0.46% |
|
-1.16% |
|
0.19% |
|
0.28% |
|
$15.62 |
|
$1.73 |
|
$2.24 |
|